Integra Lifesciences 

$11.11
0
-$0.27-2.37% Monday 05:22

統計

當日最高
11.18
當日最低
10.86
52週高點
-
52週低點
-
成交量
7,378
平均成交量
-
市值
865.38M
本益比
-
股息殖利率
-
股息
-

即將到來

財報

25Feb預期
Q3 2025
下一步
0.43
0.56
0.68
0.8
預期EPS
0.800189
實際EPS
不適用

財務

-0.43%利潤率
未盈利
2019
2020
2021
2022
2023
2024
3.22B營收
-13.89M淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 IART.BOATS 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Integra LifeSciences Holdings Corporation manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company addresses the needs of plastic, and reconstructive and general surgeons focused on the treatment of acute wounds, such as burns and chronic wounds, including diabetic foot ulcers; and provides surgical tissue repair products for hernia, tendon, peripheral nerve repair, and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. Further, it is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Show more...
執行長
Dr. Stuart M. Essig Ph.D.
員工
4396
國家
US
ISIN
US4579852082

上市

0 Comments

分享你的想法

FAQ

Integra Lifesciences 今天的股價是多少?
IART.BOATS 目前價格為 $11.11 USD,過去 24 小時下跌了 -2.37%。在圖表上更密切關注 Integra Lifesciences 股票的表現。
Integra Lifesciences 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Integra Lifesciences 的股票以代號 IART.BOATS 進行交易。
Integra Lifesciences 的市值是多少?
今天 Integra Lifesciences 的市值為 865.38M
Integra Lifesciences 下一次財報日期是什麼時候?
Integra Lifesciences 將於 February 25, 2026 公布下一次財報。
Integra Lifesciences 上一季度的財報如何?
IART.BOATS 上一季度的財報為每股 0.54 USD,預估為 0.43 USD,帶來 +24.37% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Integra Lifesciences 去年的營收是多少?
Integra Lifesciences 去年的營收為 3.22BUSD。
Integra Lifesciences 去年的淨利是多少?
IART.BOATS 去年的淨收益為 -13.89MUSD。
Integra Lifesciences 有多少名員工?
截至 February 03, 2026,公司共有 4,396 名員工。
Integra Lifesciences 位於哪個產業?
Integra Lifesciences從事於Health Care產業。
Integra Lifesciences 何時完成拆股?
Integra Lifesciences 最近沒有進行任何拆股。
Integra Lifesciences 的總部在哪裡?
Integra Lifesciences 的總部位於 US 的 Princeton。